Amanote Research
Register
Sign In
MA15.05 the Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association With Primary Response to EGFR-TKIs
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.442
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
W. Liang
C. Li
Y. Zhao
J. He
Publisher
Elsevier BV
Related search
Detection of Drug-Sensitizing EGFR Exon 19 Deletion Mutations in Salivary Gland Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Association of Exon 19 and 21 EGFR Mutation Patterns With Treatment Outcome After First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Triple Mutation Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719S), 20 (T790M) and 21 (L858R) in a Male Patient With Lung Adenocarcinoma: A Case Report
Jurnal Respirasi
EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
An Uncommon Insertion Mutation in Exon 19 of EGFR Showed Stable Disease After TKI Treatment
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combination of EGFR-TKIs With Chemotherapy Versus Chemotherapy or EGFR-TKIs Alone in Advanced NSCLC Patients With EGFR Mutation
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
EGFR Exon 19 Insertions Show Good Response to Gefitinib, but Short Time to Progression in Japanese Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Two Sides of the Same Coin: EGFR Exon 19 Deletions and Insertions in Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma With EGFR Mutation
Clinical Cancer Research
Cancer Research
Oncology